MOXD1 and neoplasm: Notably, all surviving mice in the 691-ADRN MOXD1 overexpressing (MOXD1 OE) group were tumor free at the experimental end point (365 days) as compared to the CTRL group in which all mice had tumors (Fig. 5I).